SORRENTINO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 482
EU - Europa 118
AS - Asia 98
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 704
Nazione #
US - Stati Uniti d'America 482
IT - Italia 48
VN - Vietnam 39
CN - Cina 31
UA - Ucraina 18
IE - Irlanda 15
TR - Turchia 12
PH - Filippine 10
FR - Francia 8
SE - Svezia 8
DE - Germania 5
GB - Regno Unito 4
ZA - Sudafrica 4
IN - India 3
AT - Austria 2
BG - Bulgaria 2
DK - Danimarca 2
HK - Hong Kong 2
BE - Belgio 1
CO - Colombia 1
EU - Europa 1
FI - Finlandia 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 704
Città #
Ann Arbor 101
Chandler 88
Princeton 45
Wilmington 39
Dong Ket 34
Houston 32
Jacksonville 24
Dublin 15
Izmir 12
Fairfield 11
Nanjing 8
Woodbridge 8
Andover 7
Beijing 7
Pellezzano 7
Ashburn 6
Salerno 6
Ho Chi Minh City 4
Norwalk 4
Shenyang 4
Boardman 3
Cambridge 3
Hebei 3
Jiaxing 3
Johannesburg 3
Milan 3
Boscoreale 2
Dallas 2
Düsseldorf 2
Florence 2
Nanchang 2
Napoli 2
Nocera Inferiore 2
Pannarano 2
Pune 2
San Diego 2
Sofia 2
Tianjin 2
Vienna 2
Avellino 1
Birmingham 1
Bogotá 1
Brussels 1
Budapest 1
Castellammare Di Stabia 1
Changsha 1
Copenhagen 1
Costa Mesa 1
Dearborn 1
Edinburgh 1
Falls Church 1
Fremont 1
Gunzenhausen 1
Gurgaon 1
Hangzhou 1
Hanoi 1
Highland Park 1
Hino 1
Kazan’ 1
Lincoln 1
London 1
Los Angeles 1
Nola 1
Oslo 1
Padula 1
Paris 1
Philadelphia 1
Redwood City 1
Sacramento 1
Saponara 1
Sarno 1
Stockholm 1
Vilnius 1
Totale 540
Nome #
Targeting adenosine A2b receptor reduces melanoma progression in mice: role of tumor-associated MDSCs 118
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model 109
Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target 78
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. 73
Soluble CD73 in the peripheral blood: a potential biomarker in patients with advanced melanoma receiving nivolumab 63
Expression of CD73 on CD8+/PD-1+cells as a new possible biomarker for advanced melanoma patients treated with nivolumab 60
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells 54
The A2B adenosine receptor: an emerging therapeutic target in cancer 51
Expression of CD73 on MDSCs and CD8+/PD-1+cells as new possible biomarkers for advanced melanoma patients treated with nivolumab 45
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab 42
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients 38
Notch Signaling Regulates Mitochondrial Metabolism and NF-kappa B Activity in Triple-Negative Breast Cancer Cells via IKK alpha-Dependent Non-canonical Pathways 32
Totale 763
Categoria #
all - tutte 2.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 6 16 3
2019/202080 24 1 8 1 1 1 2 2 2 10 26 2
2020/202181 0 1 6 0 6 3 8 3 3 1 8 42
2021/202280 1 0 3 0 1 3 1 4 7 12 9 39
2022/2023191 13 18 21 25 13 31 0 21 33 0 14 2
2023/202433 5 12 2 4 0 6 1 0 0 3 0 0
Totale 763